Suppr超能文献

重新评估短期中心静脉导管定期更换的必要性:一项叙述性综合综述。

Reassessing the need for scheduled replacement of short term central venous catheters: A narrative comprehensive review.

作者信息

Cohen Regev

机构信息

Infection Control and Infectious Diseases Units, Hillel Yaffe Medical Centre, Hadera, Israel.

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

Infect Prev Pract. 2024 Nov 7;6(4):100420. doi: 10.1016/j.infpip.2024.100420. eCollection 2024 Dec.

Abstract

Central venous catheters (CVCs) are essential in modern healthcare but are associated with significant risks, particularly catheter-related bloodstream infections (CRBSIs). Current guidelines do not recommend routine replacement of CVCs based on time alone. However, recent evidence challenges this recommendation. A comprehensive literature review was conducted, focusing on studies exploring the risk-factors of short-term, non-hemodialysis CVCs, that were published in the last two decades while including seminal older works for context. The guidelines regarding scheduled CVC-replacement are not based on sufficiently convincing data. Current literature establishes the significance of CVC-duration as a major risk-factor for CRBSI occurrence, especially after 9-14 days of catheter-dwelling. The daily CRBSI risk is probably not constant, and the cumulative risk may reach high rates after 9-14 days, especially for femoral and jugular insertions compared to the subclavian site, suggesting potential benefits of scheduled CVC replacement, especially for non-subclavian catheters.

摘要

中心静脉导管(CVC)在现代医疗保健中至关重要,但也伴随着重大风险,尤其是导管相关血流感染(CRBSI)。目前的指南不建议仅基于时间进行CVC的常规更换。然而,最近的证据对这一建议提出了挑战。我们进行了一项全面的文献综述,重点关注过去二十年发表的探索短期、非血液透析CVC风险因素的研究,同时纳入了早期的经典著作以作背景参考。关于定期更换CVC的指南并非基于充分令人信服的数据。当前文献证实,CVC留置时间是CRBSI发生的主要风险因素,尤其是在导管留置9 - 14天后。每日CRBSI风险可能并非恒定不变,9 - 14天后累积风险可能达到较高水平,特别是与锁骨下置管相比,股静脉和颈内静脉置管的情况,这表明定期更换CVC可能有益,尤其是对于非锁骨下导管。

相似文献

1
Reassessing the need for scheduled replacement of short term central venous catheters: A narrative comprehensive review.
Infect Prev Pract. 2024 Nov 7;6(4):100420. doi: 10.1016/j.infpip.2024.100420. eCollection 2024 Dec.
2
Sex-Disaggregated Analysis of Central Venous Catheter-Related Bloodstream Infections in Patients with Cancer.
Oncol Res Treat. 2025;48(1-2):37-47. doi: 10.1159/000542535. Epub 2024 Nov 11.
5
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Cochrane Database Syst Rev. 2016 Mar 16;3(3):CD007878. doi: 10.1002/14651858.CD007878.pub3.
6
Reassessing the Risk: A Retrospective Analysis of CLABSI Risk in Femoral, Internal Jugular, and Subclavian Central Venous Catheters.
Crit Care Res Pract. 2025 Apr 29;2025:8193419. doi: 10.1155/ccrp/8193419. eCollection 2025.

本文引用的文献

1
Risk factors of central catheter bloodstream infections in intensive care units: A systematic review and meta-analysis.
PLoS One. 2024 Apr 23;19(4):e0296723. doi: 10.1371/journal.pone.0296723. eCollection 2024.
2
Complication Rates of Central Venous Catheters: A Systematic Review and Meta-Analysis.
JAMA Intern Med. 2024 May 1;184(5):474-482. doi: 10.1001/jamainternmed.2023.8232.
4
Clinical Impacts and Risk Factors for Central Line-Associated Bloodstream Infection: A Systematic Review.
Cureus. 2023 Jun 25;15(6):e40954. doi: 10.7759/cureus.40954. eCollection 2023 Jun.
5
Risk of infections in intravascular catheters in situ for more than 10 days: a post hoc analysis of randomized controlled trials.
Clin Microbiol Infect. 2023 Sep;29(9):1200.e1-1200.e5. doi: 10.1016/j.cmi.2023.05.025. Epub 2023 May 26.
6
Risk factors of catheter- associated bloodstream infection: Systematic review and meta-analysis.
PLoS One. 2023 Mar 23;18(3):e0282290. doi: 10.1371/journal.pone.0282290. eCollection 2023.
8
Risk factors associated with increased incidences of catheter-related bloodstream infection.
Medicine (Baltimore). 2022 Oct 21;101(42):e31160. doi: 10.1097/MD.0000000000031160.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验